Verheij M - Search Results

1

Prediction of treatment outcome by cisplatin-DNA adduct formation in patients with stage III/IV head and neck squamous cell carcinoma, treated by concurrent cisplatin-radiation (RADPLAT).

Hoebers FJ, Pluim D, Verheij M, Balm AJ, Bartelink H, Schellens JH, Begg AC. Hoebers FJ, et al. Among authors: verheij m. Int J Cancer. 2006 Aug 15;119(4):750-6. doi: 10.1002/ijc.21919. Int J Cancer. 2006. PMID: 16550603 Clinical Trial.

2

The role of the stress-activated protein kinase (SAPK/JNK) signaling pathway in radiation-induced apoptosis.

Verheij M, Ruiter GA, Zerp SF, van Blitterswijk WJ, Fuks Z, Haimovitz-Friedman A, Bartelink H. Verheij M, et al. Radiother Oncol. 1998 Jun;47(3):225-32. doi: 10.1016/s0167-8140(98)00007-3. Radiother Oncol. 1998. PMID: 9681884 Review.

3

Radiation-induced apoptosis--the ceramide-SAPK signaling pathway and clinical aspects.

Verheij M, van Blitterswijk WJ, Bartelink H. Verheij M, et al. Acta Oncol. 1998;37(6):575-81. doi: 10.1080/028418698430287. Acta Oncol. 1998. PMID: 9860316

4

Towards prediction and modulation of treatment response.

Bartelink H, Begg A, Martin JC, van Dijk M, van 't Veer L, van der Vaart P, Verheij M. Bartelink H, et al. Among authors: verheij m. Radiother Oncol. 1999 Jan;50(1):1-11. doi: 10.1016/s0167-8140(99)00009-2. Radiother Oncol. 1999. PMID: 10225551 Review.

5

Alkyl-lysophospholipids activate the SAPK/JNK pathway and enhance radiation-induced apoptosis.

Ruiter GA, Zerp SF, Bartelink H, van Blitterswijk WJ, Verheij M. Ruiter GA, et al. Among authors: verheij m. Cancer Res. 1999 May 15;59(10):2457-63. Cancer Res. 1999. PMID: 10344758

6

Translational research offers individually tailored treatments for cancer patients.

Bartelink H, Begg AC, Martin JC, van Dijk M, Moonen L, van 't Veer LJ, Van de Vaart P, Verheij M. Bartelink H, et al. Among authors: verheij m. Cancer J Sci Am. 2000 Jan-Feb;6(1):2-10. Cancer J Sci Am. 2000. PMID: 10696731 Review.

7

Radiation-induced apoptosis.

Verheij M, Bartelink H. Verheij M, et al. Cell Tissue Res. 2000 Jul;301(1):133-42. doi: 10.1007/s004410000188. Cell Tissue Res. 2000. PMID: 10928286 Review.

8

Concurrent chemotherapy and radiation for locally advanced squamous cell cancers: what is the schedule of choice?

Schornagel JH, Verheij M, Bartelink H. Schornagel JH, et al. Among authors: verheij m. Curr Oncol Rep. 2001 Jan;3(1):1-2. doi: 10.1007/s11912-001-0034-3. Curr Oncol Rep. 2001. PMID: 11123863 No abstract available.

9

Apoptosis, proliferation and p53, cyclin D1, and retinoblastoma gene expression in relation to radiation response in transitional cell carcinoma of the bladder.

Moonen L, Ong F, Gallee M, Verheij M, Horenblas S, Hart AA, Bartelink H. Moonen L, et al. Among authors: verheij m. Int J Radiat Oncol Biol Phys. 2001 Apr 1;49(5):1305-10. doi: 10.1016/s0360-3016(00)01503-0. Int J Radiat Oncol Biol Phys. 2001. PMID: 11286838

10

Prognostic factors in transitional cell cancer of the bladder: an emerging role for Bcl-2 and p53.

Ong F, Moonen LM, Gallee MP, ten Bosch C, Zerp SF, Hart AA, Bartelink H, Verheij M. Ong F, et al. Among authors: verheij m. Radiother Oncol. 2001 Nov;61(2):169-75. doi: 10.1016/s0167-8140(01)00421-2. Radiother Oncol. 2001. PMID: 11690683

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

318 results

Search Page

Filters